Organization Announcements

Organization Announcements
Editor’s Note:
Careful readers will note that the number and range of organizations now monitored in our Announcements section below has grown as the impacts of the pandemic have spread across global economies, supply chains and programmatic activity of multilateral agencies and INGOs.


Paul G. Allen Frontiers Group [to 5 Jun 2021]
No new digest content identified.


BARDA – U.S. Department of HHS [to 5 Jun 2021]
No new digest content identified.


BMGF – Gates Foundation [to 5 Jun 2021]
Press Releases and Statements
Press release
Jun 02, 2021
The Bill & Melinda Gates Foundation pledges $50 million to increase access to safe and affordable COVID-19 vaccines in lower-income countries
Foundation urgently calls for high-income countries to share at least 1 billion excess COVID-19 doses with lower-income countries in 2021 to accelerate global vaccine access and save lives
SEATTLE, June 2, 2021 – The Bill & Melinda Gates Foundation today announced a $50 million commitment to Gavi, the Vaccine Alliance. The pledge will support COVID-19 vaccine purchasing through Gavi’s COVAX Advance Market Commitment (AMC) as well as delivery of these vaccines to 92 lower-income countries.
The pledge was announced at Gavi’s COVAX AMC Summit, an event co-hosted by the government of Japan and Gavi that gathered world leaders, the private sector, civil society, and technical partners to build support to procure COVID-19 vaccines and equitably distribute them to lower-income countries.
“The world must urgently come together to expand equitable access to COVID-19 vaccines, or we risk more deaths and the emergence of new variants that could prolong the pandemic for everyone,” said Mark Suzman, CEO of the Bill & Melinda Gates Foundation. “Thanks to today’s contributions, especially Japan’s generous pledge and its leadership in global health, we’ve taken an important step towards that goal. This summit is a powerful example of what can be achieved when we act collectively to control the pandemic and save lives.”…


Bill & Melinda Gates Medical Research Institute [to 5 Jun 2021]
The Bill & Melinda Gates Medical Research Institute is a non-profit biotech organization. Our mission is to develop products to fight malaria, tuberculosis, and diarrheal diseases—three major causes of mortality, poverty, and inequality in developing countries. The world has unprecedented scientific tools at its disposal; now is the time to use them to save the lives of the world’s poorest people
No new digest content identified.


CARB-X [to 5 Jun 2021]
06.01.2021  | 
CARB-X is funding Swiss pharma company BioVersys to develop a new class of antibiotics to treat infections caused by multidrug-resistant ESKAPE pathogens
CARB-X is awarding BioVersys, a pharmaceutical company headquartered in Basel, Switzerland, up to US$4.35 million in non-dilutive funding, to develop a new class of antibiotics to treat life-threatening infections caused by ESKAPE pathogens, bacteria that have developed resistance to most antibiotics available today. BioVersys could receive up to $10.98 million in additional funds from CARB-X if the project achieves certain milestones, subject to available funds.


Center for Vaccine Ethics and Policy – GE2P2 Global Foundation [to 5 Jun 2021]
:: Past weekly editions and posting of all segments of Vaccines and Global Health: The Week in Review are available here.
:: [NEW] Informed Consent: A Monthly Review – June 2021 is now posted here


CEPI – Coalition for Epidemic Preparedness Innovations [to 5 Jun 2021]
Latest News
To keep coronavirus at bay, we must create a ‘variant-proof’ world
Blog 04 Jun By Dr. Richard Hatchett
In the battle against COVID-19, humankind faces a shape-shifting enemy. The scale of the challenge has been hammered home in recent months with the emergence of multiple variants of concern as the disease has ripped through Brazil, South Africa, and now India. Sadly, there is no sign of an imminent end to the current pandemic, which has already claimed at least 3.7 million lives and is still causing more than half a million new infections every day.
The hard reality is that despite the administration of 2 billion doses of vaccine worldwide – an unprecedented achievement – we remain locked in a deadly race with the virus. While recent data shows that vaccines remain sufficiently effective against some priority variants of concern, we will only win when we have created a “variant-proof” world that can keep a lid on the havoc caused by its troublesome mutations.


DARPA – Defense Advanced Research Projects Agency [to 5 Jun 2021
No new digest content identified.


Duke Global Health Innovation Center [to 5 Jun 2021]
Last dated update: FRIDAY, April 16, 2021


EDCTP [to 5 Jun 2021]
The European & Developing Countries Clinical Trials Partnership (EDCTP) aims to accelerate the development of new or improved drugs, vaccines, microbicides and diagnostics against HIV/AIDS, tuberculosis and malaria as well as other poverty-related and neglected infectious diseases in sub-Saharan Africa, with a focus on phase II and III clinical trials
No new digest content identified.


Emory Vaccine Center [to 5 Jun 2021]
Vaccine Center News
No new digest content identified.


European Vaccine Initiative [to 5 Jun 2021]
Latest News
No new digest content identified.


FDA [to 5 Jun 2021]
Press Announcements /Selected Details
June 4, 2021 – Coronavirus (COVID-19) Update: June 4, 2021
June 1, 2021 – Coronavirus (COVID-19) Update: June 1, 2021


Fondation Merieux [to 5 Jun 2021]
News, Events
Mérieux Foundation co-organized event
8th Annual meeting of the Global Task Force on Cholera Control (GTFCC)
June 8 – 10, 2021 – Virtual Event


Gavi [to 5 Jun 2021]
News Releases
World leaders unite to commit to global equitable access for COVID-19 vaccines
2 June 2021
[See COVID above for full text]

3 June 2021
Gavi welcomes U.S. allocation plan for vaccine dose-sharing – 19 million doses donated to COVAX in first tranche
[See COVID above for full text]

2 June 2021
World leaders unite to commit to global equitable access for COVID-19 vaccines

31 May 2021
New Zealand transfers vaccine doses to COVAX – 6 Pacific nations first to benefit


GHIT Fund [to 5 Jun 2021]
GHIT was set up in 212 with the aim of developing new tools to tackle infectious diseases that
No new digest content identified.


Global Fund [to 5 Jun 2021]
News & Stories
Technical Note on Leveraging COVID-19 Response Mechanism Investments for Geographic Information Systems
01 June 2021


Global Research Collaboration for Infectious Disease Preparedness [GloPID-R] [to 5 Jun 2021]
No new digest content identified.


Hilleman Laboratories [to 5 Jun 2021]
Website not responding at inquiry


Human Vaccines Project [to 5 Jun 2021]
No new digest content identified.


IAVI [to 5 Jun 2021]
June 5, 2021
IAVI marks 40 years since the first description of AIDS
A commentary by Mark Feinberg, M.D., Ph.D., IAVI president and CEO
[Closing excerpt]
… Forty years since the first description of HIV/AIDS, we have in hand today effective treatment and prevention tools, promising new biomedical prevention modalities, and exciting proof of concept for a new vaccine strategy. Further progress toward the goals of universal access to HIV prevention tools and an effective HIV vaccine will take time and sustained investment and so, inevitably, test the patience of policymakers, advocates, funders, and scientists. But this progress must be a global priority. The only real hope we have of ending the HIV/AIDS pandemic is through the deployment of an effective HIV vaccine, one that is achieved through the work of partners, advocates, and community members joining hands to do together what no one individual or group can do on its own. The prospects of that happening have never looked more promising than they do today.



International Coalition of Medicines Regulatory Authorities [ICMRA]
Selected Statements, Press Releases, Research
No new digest content identified.


ICRC [to 5 Jun 2021]
Selected News Releases, Statements, Reports
ICRC President visits Myanmar to discuss humanitarian issues
The ICRC President Peter Maurer while on a visit to Myanmar said that the people, caught between armed conflict and COVID-19, are in urgent need of assistance and protection.
03-06-2021 | Statement



International Generic and Biosimilar Medicines Association [IGBA]
No new digest content identified.



Press Releases/Announcements
No new digest content identified.


IFRC [to 5 Jun 2021]
Selected Press Releases, Announcements
IFRC braces for hurricane season in midst of COVID-19 pandemic
Panama/Geneva, 31 May 2020 —The International Federation of Red Cross and Red Crescent Societies (IFRC) is currently mobilizing and ramping up the efforts of hundreds of Red Cross teams across the Americas to prepare for another hurricane season during …
31 May 2021


Institut Pasteur [to 5 Jun 2021]
Press Info
No new digest content identified.


IOM / International Organization for Migration [to 5 Jun 2021]
IOM Strengthens Preparedness Efforts ahead of Cyclone and Monsoon Season in Cox’s Bazar
2021-06-04 14:10
Cox’s Bazar – Cox’s Bazar, home to 900,000 Rohingya refugees, narrowly avoided Cyclone Yaas last week – the Bay of Bengal’s second major storm of the cyclone season that went on to do over USD 2 billion damage elsewhere in Bangladesh and India.

Goma Volcano Eruption Displaces 415,700 People as IOM Prepares Response
2021-06-01 16:32
Goma – The eruption of Mount Nyiragongo volcano has forced more than 415,000 people, nearly half of whom are children, to leave Goma, according to thousands of individual assessments carried out by the International Organization for Migration’s (IOM) Displacement Tracking Matrix…



IOM Announces Appointment of New Deputy Directors General
2021-05-31 19:39
Geneva – The International Organization for Migration (IOM) today announced the selection by Director General António Vitorino of two new Deputy Directors General during a special session of the IOM Member State Council in Geneva.


IRC International Rescue Committee [to 5 Jun 2021]
Media highlights [Selected]
No new digest content identified.


IVAC [to 5 Jun 2021]
Updates; Events
No new digest content identified.


IVI [to 5 Jun 2021]
Selected IVI News, Announcements, Events
IVI to develop an adaptive Phase 1b/2a schistosomiasis vaccine clinical trial
May 31, 2021 – SEOUL, South Korea – The International Vaccine Institute (IVI) announced today that the Bill & Melinda Gates Foundation awarded a grant to IVI to develop an adaptive trial design protocol for a Phase 1b/2a clinical trial of a schistosomiasis vaccine.
The grant is a Trial Planning Grant, part of the Gates Foundation’s Design, Analyze, Communicate (DAC) program which supports grantees in optimizing clinical studies for informativeness and impact. The goal of IVI’s schistosomiasis vaccine project is to advance the development of a safe, effective, and affordable vaccine to reduce morbidity and mortality from schistosomiasis in moderate- to high-transmission settings.
Dr. Florian Marks, Deputy Director General of Epidemiology, Public Health, and Impact at IVI, said: “A safe, effective, and accessible vaccine is the most sustainable solution to breaking the devastating cycle of Schistosomiasis infection and will save lives and improve the livelihoods of hundreds of millions of people. We are grateful to the Gates Foundation for their support and guidance in planning an adaptive Phase 1b/2a clinical trial for a schistosomiasis vaccine candidate which would accelerate the clinical development timeline as well as licensure and pre-qualification processes.”…


JEE Alliance [to 5 Jun 2021]
Selected News and Events
No new digest content identified.


Johns Hopkins Center for Health Security [to 5 Jun 2021]
Center News
No new digest content identified.


MSF/Médecins Sans Frontières [to 5 Jun 2021]
Latest [Selected Announcements
No new digest content identified.


National Academy of Medicine – USA [to 5 Jun 2021]
Selected News/Programs
No new digest content identified.


National Vaccine Program Office – U.S. HHS [to 5 Jun 2021]
Upcoming Meetings/Latest Updates
NVAC 2021 Meetings
June 16-17, 2021 NVAC Meeting = Agenda


NIH [to 5 Jun 2021]
News Releases
NIH researchers identify potential new antiviral drug for COVID-19
June 3, 2021 — Compound targets essential viral enzyme and prevents replication in cells.

NIH clinical trial evaluating mixed COVID-19 vaccine schedules begins
June 1, 2021 — Trial to evaluate safety, immunogenicity of various vaccine booster regimens.

NIH launches clinical trial of universal influenza vaccine candidate
June 1, 2021 — Nanoparticle vaccine developed by NIAID scientists.

U.S. blood donations are safe under current COVID-19 screening guidelines
June 1, 2021 — Researchers found no reason to alter the current blood donor screening practices that are in place.


UN OCHA Office for the Coordination of Humanitarian Affairs [to 5 Jun 2021]
Press Releases
No new digest content identified.


PATH [to 5 Jun 2021]
Press Releases
No new digest content identified.


Sabin Vaccine Institute [to 5 Jun 2021]
Statements and Press Releases
Barney S. Graham, MD, PhD receives the 2021 Albert B. Sabin Gold Medal; Sabin Vaccine Institute’s Rising Star Award presented to Nginache Nampota-Nkomba, MBBS, MSc
Thursday, June 3, 2021
Washington, D.C. – The Sabin Vaccine Institute (Sabin) today announced that it has awarded its annual Albert B. Sabin Gold Medal to Barney S. Graham, MD, PhD, deputy director, Vaccine Research Center and chief of the Viral Pathogenesis Laboratory at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. Sabin has also granted the Rising Star Award to Nginache Nampota-Nkomba, MBBS, MSc, a research physician and clinical research site leader at Blantyre Malaria Project in Malawi.
The Gold Medal, now in its 28th year, is Sabin’s highest scientific honor, given each year to a distinguished member of the global health community who has made extraordinary contributions to vaccinology or a complementary field. Past award recipients include leaders of vaccinology and vaccine advocacy such as Drs. D.A. Henderson, William Foege and Carol Baker…


UNAIDS [to 5 Jun 2021]
Selected Press Releases/Reports/Statements
4 June 2021
Hearing civil society’s voice on the High-Level Meeting on AIDS

2 June 2021
“Even though we are sex workers, we’re still people”: living the harsh reality of sex work in Zimbabwe


UNDP United Nations Development Programme [to 5 Jun 2021]
News Centre
No new digest content identified.


UNHCR Office of the United Nations High Commissioner for Refugees [to 5 Jun 2021]
Selected News Releases, Announcements
UNHCR urges stronger support for refugee vaccinations in Asia
1 Jun 2021
[See COVID above for detail]


UNICEF [to 5 Jun 2021]
Selected Press Releases, Statements
Press release
UNICEF supports 26 oxygen plants and sends over 4,000 oxygen concentrators, and other critical supplies as India continues to grapple with COVID-19

Press release
UNICEF supply operations reach record highs in 2020 amid global fight against COVID-19 pandemic
UNICEF procured supplies and services worth nearly US$4.5 billion in 2020 despite widespread disruptions to global transport and supply chains
… In its Supply Annual Report released today, UNICEF said that in 2020 it shipped more than 200 million medical masks, 195 million gloves, 5.7 million gowns, 3.3 million COVID-19 molecular diagnostic tests and 16,795 oxygen concentrators to 139 countries in support of the pandemic response.
Despite the unique challenges posed by COVID-19, UNICEF’s regular work procuring and delivering supplies for children was not interrupted. This included the delivery of over 2 billion vaccine doses to ensure vital routine immunization programmes were maintained, according to the report…

News note
UNICEF signs COVID-19 vaccine supply agreement with Moderna


Unitaid [to 5 Jun 2021]
Featured News
No new digest content identified.


Transparency International [to 5 Jun 2021]
Lack of transparency over vaccine trials, secretive contracts and ‘science by press release’ risk success of global COVID-19 response
Issued by Transparency International Global Health
A lack of transparency in COVID-19 vaccine trials and secrecy over deals between governments and drug companies risks the success of the global pandemic response, new research from Transparency…
25 May 2021


Vaccination Acceptance & Demand Initiative [Sabin) [to 5 Jun 2021]
No new digest content identified.


Vaccine Confidence Project [to 5 Jun 2021]
News, Research and Reports
Coronavirus global impact
Launched April 2, 2020 and recurring every 3 days, Premise Data is utilizing its global network of Contributors to assess economic, social, and health sentiment surrounding the coronavirus (COVID-19).


Vaccine Education Center – Children’s Hospital of Philadelphia [to 5 Jun 2021]
No new digest content identified.


Wellcome Trust [to 5 Jun 2021]
News and reports
Our open letter to the UK Prime Minister, Boris Johnson
4 June 2021
In an open letter ahead of the G7 Summit, our Director Jeremy Farrar and Steven Waugh, Executive Director at the UK Committee for UNICEF (UNICEF UK) urge the UK Prime Minister, Boris Johnson, to show historic leadership and begin sharing vaccines with the world.

Q&A :: Anna Mouser, Jeremy Farrar
Why we need fair global vaccine allocation to end Covid-19
3 June 2021


The Wistar Institute [to 5 Jun 2021]
Press Releases
Jun. 2, 2021
The Wistar Institute Announces COVID-19 Vaccine Mandate for All Employees
PHILADELPHIA — (June 2, 2021) — The Wistar Institute, an international biomedical research leader with special expertise in cancer, immunology and infectious disease research and vaccine development, will require all employees to be vaccinated against COVID-19 by July 1, 2021.

Press Release
Jun. 1, 2021
The Wistar Institute Recruits Noam Auslander, Ph.D., as Assistant Professor to Bring Artificial Intelligence Research to Its Cancer Center
PHILADELPHIA — (June 1, 2021) — The Wistar Institute, an international biomedical research leader in cancer, immunology and infectious diseases, announces the appointment of Noam Auslander, Ph.D., as assistant professor in the Molecular and Cellular Oncogenesis Program of The Wistar Institute Cancer Center.


WFPHA: World Federation of Public Health Associations [to 5 Jun 2021]
Latest News
No new digest content identified.


World Bank [to 5 Jun 2021]
Selected News, Announcements
World Bank Injects $115 Million to Boost COVID-19 Vaccination in Mozambique
WASHINGTON, June 3, 2021 —The World Bank approved today a $100 million grant from the International Development Association (IDA)* and a $15 million grant from the Global Financing Facility (GFF) in support…
Date: June 03, 2021 Type: Press Release

Safeguarding Animal, Human and Ecosystem Health: One Health at the World Bank
Overview: Increasing interactions between humans and animals, the erosion of biodiversity, alteration of ecosystems, and climate change are increasingly driving the emergence of infectious diseases, most of them from animals, and sometimes with the potential to become pandemics…
Date: June 03, 2021 Type: Brief
…The “One Health” approach proactively engages different disciplines, such as human medicine, veterinary medicine, and environmental health sciences, to attain optimal health for people, animals and our environment.
:: One Health can help achieve progress on national and global priorities. Strengthening public health systems at the human-animal-environment interface protects health, agricultural production, and ecosystem services—including food and nutrition security to disaster resilience and ecotourism–all of which contribute to economic development.
:: Actions to address disease risk and prevent disease emergence at the source are a key part of the One Health approach. This includes improving animal health and welfare.
:: The One Health approach promotes synergies at national and global levels. The One Health approach is endorsed by international agencies such as WHO, FAO, OIE and their Tripartite alliance.
:: One Health strategies are highly cost-effective. One Health improves effectiveness of core public health systems, substantially reducing morbidity, mortality, and economic costs of outbreaks.
… The World Bank has over US$ 1.5 billion on One Health in operations, including livestock and agriculture projects that include One Health approaches, and One Health-oriented projects that focus entirely on reducing the risk of emerging health threats…

Call to Action on COVID Vaccine Access for Developing Countries by Heads of World Bank Group and International Monetary Fund
WASHINGTON, June 3, 2021—David Malpass, President of the World Bank Group, and Kristalina Georgieva, Managing Director of the International Monetary Fund, today issued the following joint statement to…
Date: June 03, 2021 Type: Statement
[See COVID above for detail]

New World Bank Support to Enable Equitable Access to COVID-19 Vaccines in Senegal
WASHINGTON, June 2, 2021 — The World Bank’s Board of Executive Directors approved $134 million (half of the funds in grants), from the International Development Association (IDA) to enable safe, affordable…
Date: June 02, 2021 Type: Press Release

Remarks by World Bank Group President David Malpass at the World Health Organization Media Briefing on COVID-19 and Vaccine Equity
I join my colleagues in expressing the urgency to quickly make approved vaccines available to everyone.   My immediate priority is for countries that have sufficient supply to quickly release doses…
Date: June 01, 2021 Type: Speeches and Transcripts
[See COVID above for detail]


World Customs Organization – WCO [to 5 Jun 2021]
Latest News – Selected Items
03 June 2021
The WCO COVID-19 Project supports Madagascar Customs in enhancing its preparedness by drafting Standard Operating Procedures to expedite the movement of relief goods and humanitarian aid


World Organisation for Animal Health (OIE) [to 5 Jun 2021]
Press Releases
No new digest content identified.


WTO – World Trade Organisation [to 5 Jun 2021]
WTO News and Events
New $50 billion health, trade and finance roadmap to end the pandemic and secure a global recovery
1 June 2021
The heads of the world’s predominant global financing, health and trade agencies have united to urge government leaders to urgently finance a new $50 billion roadmap to accelerate the equitable distribution of health tools to help end the pandemic that has devastated lives and livelihoods for 18 months and also set the foundations for a truly global recovery, as well as enhanced health security.
[See COVID above for detail]



ARM [Alliance for Regenerative Medicine] [to 5 Jun 2021]
Press Releases – Alliance for Regenerative Medicine (
Selected Press Releases
No new digest content identified.


BIO [to 5 Jun 2021]
Press Releases
No new digest content identified.


DCVMN – Developing Country Vaccine Manufacturers Network [to 5 Jun 2021]
News; Upcoming events
No new digest content identified.


ICBA – International Council of Biotechnology Associations [to 5 Jun 2021]
No new digest content identified.


IFPMA [to 5 Jun 2021]
Selected Press Releases, Statements, Publications
Government and Life Science Industry Join Forces on 100 Days Mission for Future Pandemics
04 June 2021
[See COVID above for deatil]


PhRMA [to 5 Jun 2021]
Selected Press Releases, Statements
No new digest content identified.